The Future of Obesity Care Goes Far Beyond Ozempic, Wegovy, and Zepbound
Source ↗
👁 0
💬 0
Experts say the future of obesity treatment will extend far beyond GLP-1 drugs by combining medications with personalized therapies and advanced procedures. The arrival of GLP-1 medications such as semaglutide (Wegovy, Ozempic, Rybelsus) and tirzepatide (Mounjaro, Zepbound) has dramatically changed how obesity is treated. But while these drugs have produced impressive results, experts say they [...]
Comments (0)